These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I. Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213 [Abstract] [Full Text] [Related]
3. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J. Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015 [Abstract] [Full Text] [Related]
4. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Majumder K, Gelbaya TA, Laing I, Nardo LG. Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579 [Abstract] [Full Text] [Related]
5. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles. Tolikas A, Tsakos E, Gerou S, Prapas Y, Loufopoulos A. Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130 [Abstract] [Full Text] [Related]
6. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Elgindy EA, El-Haieg DO, El-Sebaey A. Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520 [Abstract] [Full Text] [Related]
7. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G. Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092 [Abstract] [Full Text] [Related]
8. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E, Yin L, Matos-Bodden L, Leader B, Stadtmauer L. Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663 [Abstract] [Full Text] [Related]
9. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?]. Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S, Mayenga JM, Kulski O, Cohen-Bacrie P, Benaim JL, Belaisch-Allart J. Gynecol Obstet Fertil; 2012 Aug; 40(7-8):411-8. PubMed ID: 22521986 [Abstract] [Full Text] [Related]
10. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. McIlveen M, Skull JD, Ledger WL. Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197 [Abstract] [Full Text] [Related]
11. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients? Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870 [Abstract] [Full Text] [Related]
12. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782 [Abstract] [Full Text] [Related]
13. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders". Ho JY, Guu HF, Yi YC, Chen MJ, Ho ES. Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795 [Abstract] [Full Text] [Related]
14. Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Gleicher N, Weghofer A, Barad DH. Fertil Steril; 2010 Dec; 94(7):2824-7. PubMed ID: 20538269 [Abstract] [Full Text] [Related]
15. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E. Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961 [Abstract] [Full Text] [Related]
16. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? Lee Y, Kim TH, Park JK, Eum JH, Lee HJ, Kim J, Lyu SW, Kim YS, Lee WS, Yoon TK. Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180 [Abstract] [Full Text] [Related]
17. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R. Hum Reprod; 2009 Apr; 24(4):867-75. PubMed ID: 19136673 [Abstract] [Full Text] [Related]
18. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Weghofer A, Dietrich W, Barad DH, Gleicher N. Hum Reprod; 2011 Jul; 26(7):1905-9. PubMed ID: 21531994 [Abstract] [Full Text] [Related]
19. Utility of age-specific serum anti-Müllerian hormone concentrations. Barad DH, Weghofer A, Gleicher N. Reprod Biomed Online; 2011 Mar; 22(3):284-91. PubMed ID: 21269880 [Abstract] [Full Text] [Related]
20. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth? Wang S, Zhang Y, Mensah V, Huber WJ, Huang YT, Alvero R. J Ovarian Res; 2018 Jul 16; 11(1):60. PubMed ID: 30012195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]